Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases

MAA Al‐Bari - Pharmacology research & perspectives, 2017 - Wiley Online Library
Emerging viruses such as HIV, dengue, influenza A, SARS coronavirus, Ebola, and other
viruses pose a significant threat to human health. Majority of these viruses are responsible …

[HTML][HTML] Rethinking the role of hydroxychloroquine in the treatment of COVID‐19

EA Meyerowitz, AGL Vannier, MGN Friesen… - The FASEB …, 2020 - ncbi.nlm.nih.gov
There are currently no proven or approved treatments for coronavirus disease 2019 (COVID‐
19). Early anecdotal reports and limited in vitro data led to the significant uptake of …

Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study

P Deepak, W Kim, MA Paley, M Yang… - Annals of internal …, 2021 - acpjournals.org
Background: Patients with chronic inflammatory disease (CID) treated with
immunosuppressive medications have increased risk for severe COVID-19. Although mRNA …

2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases

AR Bass, E Chakravarty, EA Akl… - Arthritis care & …, 2023 - Wiley Online Library
Objective To provide evidence‐based recommendations on the use of vaccinations in
children and adults with rheumatic and musculoskeletal diseases (RMDs). Methods This …

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

V Furer, C Rondaan, MW Heijstek… - Annals of the …, 2020 - ard.bmj.com
To update the European League Against Rheumatism (EULAR) recommendations for
vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

[HTML][HTML] Glucocorticoids and B cell depleting agents substantially impair immunogenicity of mRNA vaccines to SARS-CoV-2

P Deepak, W Kim, MA Paley, M Yang, AB Carvidi… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Background: Individuals with chronic inflammatory diseases (CID) are frequently treated with
immunosuppressive medications that can increase their risk of severe COVID-19. While …

Vaccination and immunotherapies in neuroimmunological diseases

A Winkelmann, M Loebermann, M Barnett… - Nature Reviews …, 2022 - nature.com
Neuroimmunological diseases and their treatment compromise the immune system, thereby
increasing the risk of infections and serious illness. Consequently, vaccinations to protect …

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 …

C Rondaan, V Furer, MW Heijstek, N Agmon-Levin… - RMD open, 2019 - rmdopen.bmj.com
Aim To present a systematic literature review (SLR) on efficacy, immunogenicity and safety
of vaccination in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD) …

The use of COVID-19 vaccines in patients with SLE

W Tang, Y Gartshteyn, E Ricker, S Inzerillo… - Current rheumatology …, 2021 - Springer
Abstract Purpose of Review Three COVID-19 vaccines obtained emergency authorization
from the Food and Drug Administration (FDA) and are widely used in the USA …

Vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies

KA Papp, B Haraoui, D Kumar… - Journal of …, 2019 - journals.sagepub.com
Background: Patients with immune-mediated diseases on immunosuppressive therapies
have more infectious episodes than healthy individuals, yet vaccination practices by …